- About Us
- Services & Solutions
- Technologies
- Discovery
- Reagent Materials Generation
- Monoclonal Antibody Discovery
- Bispecific & Multispecific Antibody Generation
- Lead Optimization
- In Vitro Lead Characterization
- In Vivo Lead Characterization
- Other Molecular Modalities
- IND Filing Support
- Protein Sciences
- Antibody Production
- Protein Production
- Protein Characterization
- Protein Sciences
- Mammalian
- Microbial
- mRNA
- Viral Vaccines
- WuXi XDC – Bioconjugation
- Testing
- Sustainability
- Careers
- Investors
- News & Resources
WuXi Biologics
Offering End-to-End Solutions
- About Us
About Us - Services & SolutionsAbout Us
- SustainabilityAbout Us
- CareersAbout Us
- InvestorsAbout Us
- News & ResourcesAbout Us
Continuous manufacturing process
At WuXi Biologics, continuous manufacturing process technology is combined with intensified perfusion culture (IPC) and continuous direct product capture (CDPC) to form the WuXiUPTM technology platform. This platform merges state-of-the-art equipment, including ATF (alternating tangential flow), BioSMB (bio-simulated moving bed), PCC (periodic counter-current chromatography) and Raman spectroscopy. The WuXiUPTM platformprovides a significantbenefit because it increases productivity while reducing costs that are associated with consumption of media and buffers. See this article for more information.
